Drug-Eluting Stents and Late Adverse Clinical Outcomes
- 4 April 2006
- journal article
- editorial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 47 (10) , 2112-2115
- https://doi.org/10.1016/j.jacc.2006.03.019
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Two-Year Outcomes After Sirolimus-Eluting Stent ImplantationJournal of the American College of Cardiology, 2006
- Sirolimus-Eluting Stents Remain Superior to Bare-Metal Stents at Two YearsJournal of the American College of Cardiology, 2006
- Sirolimus and Paclitaxel on Polymer-Based Drug-Eluting Stents: Similar But DifferentPublished by Elsevier ,2006
- Randomized Trial of a Nonpolymer-Based Rapamycin-Eluting Stent Versus a Polymer-Based Paclitaxel-Eluting Stent for the Reduction of Late Lumen LossCirculation, 2006
- Coronary Stent Thrombosis in the Current Drug-Eluting Stent Era: Insights From the ERACI III TrialJournal of the American College of Cardiology, 2006
- Allergic Reactions After the Implantation of Drug-Eluting StentsJournal of the American College of Cardiology, 2006
- Sirolimus-Eluting Stents Associated With Paradoxic Coronary VasoconstrictionJournal of the American College of Cardiology, 2005
- Endothelial Progenitor Cell Capture by Stents Coated With Antibody Against CD34: The HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) RegistryPublished by Elsevier ,2005
- Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary modelCardiovascular Research, 2004
- Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting StentCirculation, 2004